NovoLog FlexPen Sales Data

Rank 34 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows NovoLog FlexPen U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 34 (1) 7.84% 1.13%
Q3 2013 33 (6) 4.54% -2.82%
Q2 2013 39 (4) 2.10% 3.49%
Q1 2013 43 (1) 7.97% -1.52%
Q4 2012 42 (9) 8.43% 10.32%
Q3 2012 51 (12) 11.89% 3.28%
Q2 2012 63 (11) 6.49% 6.67%
Q1 2012 74 (2) 8.96% 13.81%
Q4 2011 76 (4) 10.19% 6.73%
Q3 2011 80 (6) 4.15% 4.92%
Q2 2011 86 (7) 3.71% 29.60%
Q1 2011 93

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web4)